Table 4.
Study | Hospital stay | Mortality | Overall morbidity | Re-operation | Pancreatic fistula | Tumour size (cm) | PDAC | Margin positivity | Lymph node harvest |
Asbun et al[35] | 8/12.4a | 5.7%/8.8% | NS | 3.8%/7% | 16.7%/17.3% | 2.74/3.14 | 41.5%/46.5% | 5.1%/17% | 23.44/16.84a |
Kuroki et al[36] | N/A | N/A | NS | N/A | 45%/39% | N/A | 0/12.9% | N/A | N/A |
Zureikat et al[37] | 8/8.5 | 7%/0% | 62%/42.8% | 7%/7% | 36%/42.8% | 2.2/3.6a | 57%/57% | 0/8.3% | 18.5/19.1 |
Cho et al[38] | 16.4/15.6 | 0 | 27%/27% | N/A | 13%/13% | N/A | 6.7%/13.3% | 0 | 18.5/20 |
Summary of minimally invasive pancreaticoduodenectomy (MIPD) series comparing the post-operative outcomes in MIPD and open pancreaticoduodenectomy (OPD). The results are shown as “MIPD/OPD”;
P < 0.05. N/A: Data not available.